http://finance.yahoo.com/news/trading-ahead-u...00683.html
Trading Ahead of Upcoming Developments -- New Research on Trans-Pacific Aerospace Company, Pharmacyte Biotech, First Mining Finance, and Accretive Health
22 hours ago
NEW YORK, NY / ACCESSWIRE / February 1, 2016 / Moments ago, Trader's Choice released new research updates concerning several important developing situations including the following equities: Trans-Pacific Aerospace Company Inc. (TPAC), Pharmacyte Biotech Inc. (PMCB), First Mining Finance Corp. (FFMGF) and Accretive Health Inc. (ACHI). Trader's Choice has perfected the profitable art of picking stocks, cutting through the noise to deliver the top trade, every year. The full Research Packages are being made available to the public on a complimentary basis.
TPAC Research Package: http://www.traders-choice.com/pdf?s=TPAC
Highlights from today's reports include:
On Friday, January 29, 2016, NASDAQ Composite ended at 4,613.95, up 2.38%, Dow Jones Industrial Average advanced 2.47%, to finish the day at 16,466.30, and the S&P 500 closed at 1,940.24, up 2.48%.
- Trans-Pacific Aerospace Company Inc.'s stock edged higher by 18.18% to close Friday's session at USD 0.0052. The company's shares oscillated between USD 0.0045 and USD 0.0054. The stock recorded a trading volume of 34.87 million shares, much below its 50-day daily average volume of 60.19 million shares and its 52-week average volume of 84.11 million shares. Over the last three days Trans-Pacific Aerospace Company Inc.'s shares have advanced 33.33% and in the past one week the stock has moved up 26.83%. Furthermore, over the past six months the stock has gained 1200.00%. On a compounded total return basis, the company has returned 100.00% in the past one month. Besides, the stock has an RSI (Relative Strength Index) of 40.91. Additionally, the stock has beta of -2.94.
